BMRNBioMarin PharmaceuticalHealth Care
$54.80EarningsOct 26, 2026
1D—1W—1M—3M—1Y—
Market cap$10.6BCompany infoRevenue$3.4B52-wk range$50 – $70IndustryBiotechnologyWebsitebiomarin.comRelated—
Yahoo
EDGAR
CNN
FinvizMarket Beat
Perform
n/a
1 Year
n/a1 Month
n/a1 Week
n/a1 Day
Rank Durability
Persist
n/a
1 Year
n/a6 Month
n/a3 Month
n/aTrend Hold
Business Beat
Profit
n/a
Composite
n/aRevenue
n/aMargin
n/aCash Flow
Money Flow
Pressure
n/a
60 Day
n/a30 Day
n/a5 Day
n/a2 Day
▲ +1.4% · 1YSPY
Weekly rank vs S&P 500 · 52wk
Not enough history to plot
ValuationHow the price is priced — vs cohort and vs its own past
MetricValueUnivSect5-yr range
P / E140.5×34
16
966
P / S3.1×4253
3
9
P / FCF14.5×6472
13
868
EV / EBITDA36.2×810
11
343
P / E (fwd)———
ProfitabilityMargins and returns on capital
MetricValueUnivSect5-yr range
Gross margin75.5%8880
74%
81%
Operating margin8.0%2631
-4%
25%
Net margin2.1%1727
-3%
21%
ROE1.2%1325
-2%
12%
ROIC1.6%1120
-1%
9%
Financial healthLeverage and liquidity
MetricValueUnivSect5-yr range
Debt / equity0.665048
0.1
0.7
Net debt / EBITDA8.6×44
Current ratio2.397664
Interest coverage3.3×3230
Per shareTTM, with year-over-year change
Revenue / share$17.55▲ +11%
EPS (diluted)$0.39▼ −88%
FCF / share$3.77▲ +6%
Est. EPS growth (fwd)—